{"content":[{"text":"Ageing and Aged Care publication list November 2020","bbox":{"left":0.293709,"top":0.099236,"width":0.412709,"height":0.015947000000000003}},{"text":"(MACH Care of the Ageing Committee members’ bolded)","bbox":{"left":0.286569,"top":0.129224,"width":0.42868599999999996,"height":0.01594699999999999}},{"text":"1. Microstructural degeneration and cerebrovascular risk burden underlying executive dysfunction \n after stroke. Scientific Reports, Volume 10, Issue 1, 1 December 2020, Article number 17911. \n Oublished online November 2020.","bbox":{"left":0.121,"top":0.189817,"width":0.750618,"height":0.05246799999999999}},{"text":"Veldsman M., Werden E., Egorova N., Khlif M.S., Brodtmann A.","bbox":{"left":0.121,"top":0.256658,"width":0.47322,"height":0.01594699999999999}},{"text":"About the Research: Executive dysfunction affects 40% of stroke patients, but is poorly predicted by \n characteristics of the stroke itself. Stroke typically occurs on a background of cerebrovascular \n burden, which impacts cognition and brain network structural integrity. We used structural equation \n modelling to investigate whether measures of white matter microstructural integrity (fractional \n anisotropy and mean diffusivity) and cerebrovascular risk factors better explain executive \n dysfunction than markers of stroke severity.","bbox":{"left":0.120999,"top":0.288428,"width":0.754457,"height":0.09583999999999998}},{"text":"Link to Publication","bbox":{"left":0.121,"top":0.400091,"width":0.13856800000000002,"height":0.01594699999999999}},{"text":"2. Reduced striatal vesicular monoamine transporter 2 in REM sleep behavior disorder: imaging \n prodromal parkinsonism. Scientific Reports, Volume 10, Issue 1, 1 December 2020, Article number \n 17631. Published online November 2020.","bbox":{"left":0.121,"top":0.46395,"width":0.733148,"height":0.05276500000000006}},{"text":"Beauchamp L.C., Villemagne V.L., Finkelstein D.I., Doré V., Bush A.I., Barnham K.J., Rowe C.C.","bbox":{"left":0.121,"top":0.530756,"width":0.695246,"height":0.015947000000000044}},{"text":"About the Research: Motor deficits in parkinsonism are caused by degeneration of dopaminergic \n nigral neurons. The success of disease-modifying therapies relies on early detection of the \n underlying pathological process, leading to early interventions in the disease phenotype.","bbox":{"left":0.121,"top":0.562858,"width":0.728442,"height":0.04771700000000012}},{"text":"Link to Publication","bbox":{"left":0.121,"top":0.626694,"width":0.13856800000000002,"height":0.015947000000000044}},{"text":"3. Effects of protein supplementation on muscle wasting disorders: A brief update of the evidence. \n Australasian Journal on Ageing, Volume 39, Issue S2, 1 October 2020, Pages 3-10","bbox":{"left":0.121,"top":0.703024,"width":0.749469,"height":0.03435600000000005}},{"text":"Kirk B., Iuliano S., Daly R.M., Duque G.","bbox":{"left":0.121,"top":0.751753,"width":0.28618400000000005,"height":0.015947000000000044}},{"text":"About the Research: To examine the effects of protein supplementation on muscle mass, strength \n and function in individuals at risk of muscle wasting disorders.","bbox":{"left":0.120999,"top":0.783523,"width":0.738205,"height":0.03198000000000012}},{"text":"Link to Publication","bbox":{"left":0.121,"top":0.831326,"width":0.13856800000000002,"height":0.015947000000000044}},{"text":"1","bbox":{"left":0.870172,"top":0.926071,"width":0.009365999999999985,"height":0.015947000000000044}}],"images_bbox":[{"left":0.120958,"top":0.042043,"width":0.247341,"height":0.056413},{"left":0.724318,"top":0.047981,"width":0.219236,"height":0.046734}],"images_bbox_not_text_overlap":[{"left":0.120958,"top":0.042043,"width":0.247341,"height":0.056413},{"left":0.724318,"top":0.047981,"width":0.219236,"height":0.046734}]}